CAS: 862366-25-4
Imatinib-d8 Hydrochloride
Controlled ProductCAS:862366-25-4
Formula:
C29H23D8N7O·xHCl
Color and Shape:
Neat
Molecular weight:
501.65 + x(36.46)
Ref: TR-I267983
1mg | 598.00 € | ||
5mg | 2,128.00 € | ||
10mg | 3,814.00 € |
Estimated delivery in United States, on Monday 28 Oct 2024
Imatinib Hydrochloride
CAS:862366-25-4
Applications Imatinib Hydrochloride is a tyrosine kinase inhibitor. It is a COVID19-related research product. References …
Formula:
C29H31N7O·ClH
Color and Shape:
Neat
Molecular weight:
530.06
Ref: TR-I267980
1g | 1,658.00 € | ||
100mg | 259.00 € | ||
500mg | 1,087.00 € |
Estimated delivery in United States, on Monday 28 Oct 2024
Imatinib hydrochloride
CAS:862366-25-4
Imatinib is a hydrated, desmethyl imatinib that belongs to the group of anhydrase inhibitors. It …
Formula:
C29H32ClN7O
Purity:
Min. 95%
Molecular weight:
530.1 g/mol
Ref: 3D-MJB36625
500mg | To inquire |
Estimated delivery in United States, on Friday 29 Nov 2024
Imatinib hydrochloride
CAS:862366-25-4
Imatinib: treats CML/GISTs, inhibits v-Abl/c-Kit/PDGFR (IC50: 0.6/0.1/0.1 μM).
Formula:
C29H32ClN7O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
530.06
Ref: TM-T22859
25mg | 1,410.00 € | ||
50mg | 1,851.00 € | ||
100mg | 2,337.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024